Early diagnosis and detection of diseases before they evolve and take up shape is are critical saving millions of lives every year. In recent years, progress has been made in using computers and machine learning to enhance traditional diagnosis, but more […]
Appili Therapeutics, a Nova Scotia, Canada-based biotech startup that focuses on drug development for infectious diseases, announced Tuesday it has received over $10 million in new funding from the US Department of Defense for biodefense vaccine candidate ATI-1701. As part of […]
Amberstone Biosciences, a Laguna Hills, California-based biotech startup that is focused on discovering novel immunotherapies, announced today it has secured $12 million in Series A funding to develop immunotherapeutics to treat solid tumors cancers, and other diseases. The round was led by Viva BioInnovator, […]
Who said you can’t make billions while claiming to save lives? The pharmaceutical industry has minted at least nine billionaires since the covid pandemic started almost two years ago. The “booster jabs have become easy money for Pfizer and Moderna” as the two companies […]
As you may recall, Amazon founder Jeff Bezos stepped down as CEO back in July to spend more time on philanthropy and passion projects like his space company Blue Origin. Former AWS executive Andy Jassy later takes over as the CEO […]
Between 2009 and 2019, spending on mental health care in the United States increased by more than 50%, reaching $225 billion, and a Lancet Commission report estimates the global economic cost will reach $16 trillion by 2030. Gilgamesh Pharmaceuticals is a […]
Cumulus Neuroscience (formerly known as BrainWaveBank) is a Belfast, Ireland-based biotech startup developing faster and more effective tools to help solve the biggest healthcare challenges in neurodegeneration and psychiatry. Cumulus has created a next-generation integrated physiological and digital biomarker platform. In clinical trials, Cumulus […]
